subject: Global Drug Eluting Balloons (deb) Pipeline Analysis, Opportunity Assessment And Market Forecasts To [print this page] Summary Summary
Global Drug Eluting Balloons (DEB) Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 provides key data, information and analysis on the global drug eluting balloons (DEB) market, a key segment within the medical device industyr. The report provides market landscape, competitive landscape and market trends information the drug eluting balloons (DEB) market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings. Drug Eluting Balloons (DEB) have recently come into the limelight following the Conformit Europenne (CE) approval of several DEB products and their consequent launch in Europe. The recently concluded clinical trials in Europe have produced superior results to the current interventions for a large number of indications such as in-stent restenosis, peripheral vascular disease and bifurcation lesions. The global drug eluting balloons (DEBs) market was valued at $60m in 2009 and is expected to be driven by increased adoption by physicians as long term clinical data is released, and as the device is adopted for newer indications such as peripheral vascular disease.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.
